Strategic Director, Global Drug Development Programs

Keros Therapeutics, Inc.; Lexington (MA); Presencial; USD 201.000 - 239.000; Jornada completa

Descripción de la vacante

Keros Therapeutics, Inc. is seeking a Director of Program Management to lead the rinvatercept development program.

You will drive cross-functional planning and execution across Clinical Development, Regulatory, CMC, Nonclinical, Biometrics and Medical Affairs, ensuring timely decisions and risk mitigation. The role requires strong drug-development leadership with experience guiding Phase 1–3 trials, program strategy, governance, and collaboration with senior management.

Formación

• 10+ years in biotech/pharma drug development.
• 5+ years in program management leadership.
• Experience leading Phase 1–3 programs.
• Strong cross-functional collaboration and communication.
• Boston-area residence or relocation willingness.
• Travel up to 10% as needed.

Responsabilidades

• Provide strategic and operational leadership for rinvatercept development.
• Lead cross-functional program planning and execution across Clinical Development, Regulatory, CMC, Biometrics and Commercial.
• Guide program through proof of concept, registration-enabling studies, regulatory submissions and potential marketing authorization.
• Translate development strategy into objectives, priorities and deliverables.
• Maintain governance, risk management and budget oversight for the program.
• Foster strong relationships with functional leaders and executive stakeholders.

Conocimientos

Biotech drug development

Program management

Cross-functional leadership

Clinical development

Budget management

Stakeholder communication

Educación

Bachelor's degree in science

Advanced degree preferred

Descripción del empleo

Keros Therapeutics, Inc. is seeking a Director of Program Management to lead the rinvatercept development program.

You will drive cross-functional planning and execution across Clinical Development, Regulatory, CMC, Nonclinical, Biometrics and Medical Affairs, ensuring timely decisions and risk mitigation. The role requires strong drug-development leadership with experience guiding Phase 1–3 trials, program strategy, governance, and collaboration with senior management.